508
Views
16
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

LPS interactions with immobilized and soluble antimicrobial peptides

, &
Pages 194-200 | Received 26 Jun 2009, Accepted 16 Jan 2010, Published online: 16 Mar 2010

References

  • Cohen J. The immunopathogenesis of sepsis. Nature 2002;420:885–91.
  • Lepper PM, Held TK, Schneider EM, Bolke E, Gerlach H, Trautmann M. Clinical implications of antibiotic-induced endotoxin release in septic shock. Intensive Care Med 2002;28:824–33.
  • Andra J, Gutsmann T, Garidel P, Brandenburg K. Mechanisms of endotoxin neutralization by synthetic cationic compounds. J Endotoxin Res 2006;12:261–77.
  • Brown KL, Hancock RE. Cationic host defense (antimicrobial) peptides. Curr Opin Immunol 2006;18:24–30.
  • Kamysz W. Are antimicrobial peptides an alternative for conventional antibiotics? Nucl Med Rev Cent East Eur 2005;8:78–86.
  • Kojika M, Sato N, Yaegashi Y, Suzuki Y, Suzuki K, Nakae H, Endo S. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity. Ther Apher Dial 2006;10:12–8.
  • Hanasawa K. Extracorporeal treatment for septic patients: new adsorption technologies and their clinical application. Ther Apher 2002;6:290–5.
  • Shimizu T, Endo Y, Tsuchihashi H, Akabori H, Yamamoto H, Tani T. Endotoxin apheresis for sepsis. Transfus Apher Sci 2006;35:271–82.
  • Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009;301:2445–52.
  • Scott MG, Gold MR, Hancock RE. Interaction of cationic peptides with lipoteichoic acid and gram-positive bacteria. Infect Immun 1999;67:6445–53.
  • Nell MJ, Tjabringa GS, Wafelman AR, Verrijk R, Hiemstra PS, Drijfhout JW, Grote JJ. Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application. Peptides 2006;27:649–60.
  • Lockwood NA, Haseman JR, Tirrell MV, Mayo KH. Acylation of SC4 dodecapeptide increases bactericidal potency against Gram-positive bacteria, including drug-resistant strains. Biochem J 2004;378:93–103.
  • Ding JL, Zhu Y, Ho B. High-performance affinity capture-removal of bacterial pyrogen from solutions. J Chromatogr B Biomed Sci Appl 2001;759:237–46.
  • Farley MM, Shafer WM, Spitznagel JK. Lipopolysaccharide structure determines ionic and hydrophobic binding of a cationic antimicrobial neutrophil granule protein. Infect Immun 1988;56:1589–92.
  • Goh YY, Frecer V, Ho B, Ding JL. Rational design of green fluorescent protein mutants as biosensor for bacterial endotoxin. Protein Eng 2002;15:493–502.
  • Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002;415:389–95.
  • Ciornei CD, Sigurdardottir T, Schmidtchen A, Bodelsson M. Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37. Antimicrob Agents Chemother 2005;49:2845–50.
  • Scott MG, Yan H, Hancock RE. Biological properties of structurally related alpha-helical cationic antimicrobial peptides. Infect Immun 1999;67:2005–9.
  • Ding JL, Ho B. A new era in pyrogen testing. Trends Biotechnol 2001;19:277–81.
  • Nilsson A, Fant C, Nyden M, Holmberg K. Lipopolysaccharide removal by a peptide-functionalized surface. Colloids Surf B Biointerfaces 2005;40:99–106.
  • Santos NC, Silva AC, Castanho MA, Martins-Silva J, Saldanha C. Evaluation of lipopolysaccharide aggregation by light scattering spectroscopy. Chembiochem 2003;4:96–100.
  • Mayo KH, Haseman J, Young HC, Mayo JW. Structure-function relationships in novel peptide dodecamerswith broad-spectrum bactericidal and endotoxin-neutralizing activities. Biochem J 2000;349Pt 3:717–28.
  • Behre G, Schedel I, Nentwig B, Wormann B, Essink M, Hiddemann W. Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins. Antimicrob Agents Chemother 1992;36:2139–46.
  • Gutsmann T, Howe J, Zahringer U, Garidel P, Schromm AB, Koch MHJ, Fujumoto Y, Fukase K, Moriyon I, Martinez-de-Tejada G, Brandenburg K. Structural prerequisites for endotoxic activity in the Limulus test as compared to cytokine production in mononuclear cells. Innate Immun 2010;16:39–47.
  • Ginsburg I. Role of lipoteichoic acid in infection and inflammation. Lancet Infect Dis 2002;2:171–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.